Clinical characteristics and gene mutation analysis of an adult patient with ETFDH‑related multiple acyl‑CoA dehydrogenase deficiency

Autor: Yuping Ma, Chenyi Wang, Qian Li, Haihong Lv, Xia Xu
Rok vydání: 2020
Předmět:
Adult
Iron-Sulfur Proteins
0301 basic medicine
Cancer Research
Electron-Transferring Flavoproteins
Prenatal diagnosis
Biology
medicine.disease_cause
Polymorphism
Single Nucleotide

Biochemistry
03 medical and health sciences
chemistry.chemical_compound
Exon
0302 clinical medicine
multiple acyl-CoA dehydrogenase deficiency
Genetics
medicine
Humans
DNA sequencing
Age of Onset
riboflavin
Multiple Acyl Coenzyme A Dehydrogenase Deficiency
Multiple Acyl-CoA Dehydrogenase Deficiency
Molecular Biology
Gene
Oxidoreductases Acting on CH-NH Group Donors
Mutation
Muscle biopsy
Fatty acid metabolism
medicine.diagnostic_test
Homozygote
Exons
Sequence Analysis
DNA

Articles
Pedigree
030104 developmental biology
Amino Acid Substitution
ETFDH
Oncology
chemistry
030220 oncology & carcinogenesis
Molecular Medicine
Female
point mutation
Isoleucine
Zdroj: Molecular Medicine Reports
ISSN: 1791-3004
1791-2997
Popis: Multiple acyl-CoA dehydrogenase deficiency (MADD) is a rare autosomal recessive disorder of fatty acid metabolism caused by defects in electron transfer flavoprotein (ETF) or electron transfer flavoprotein dehydrogenase (ETFDH). These defects are mainly classified into the neonatal and late-onset types, based on their clinical manifestations. ETFDH gene mutations are generally considered to be associated with the late-onset type. The present study reported an adult woman with late-onset MADD accompanied with biochemical and muscle biopsy findings indicating metabolic disorders. Gene sequencing analysis showed that the c.1514T>C homozygous mutation in the region of the 12th exon of the ETFDH gene, which led to the amino acid substitution p.I505T (isoleucine > threonine), resulting in defective ETFDH protein function. The results of family verification revealed that the homozygous mutation originated from her parents. The female patient was treated with a large dose of vitamin B2, L-carnitine and coenzyme Q10, and the symptoms were significantly relieved. The c.1514T>C mutation in the ETFDH gene, was considered as a novel pathogenic mutation that had not been previously reported. Therefore, it was hypothesized that this mutation was responsible for the clinical characteristics of the adult female patient. Overall, this novel mutation could expand the spectrum of the ETFDH gene mutation and provide the basis for the etiological and prenatal diagnosis of MADD.
Databáze: OpenAIRE